This will count as one of your downloads.
You will have access to both the presentation and article (if available).
Our group has sought to rethink common SERS methodologies in order to produce translational technologies capable of allowing SERS to compete in the evolving, yet often inflexible biosensing field. This work will discuss the development of two techniques for quantification of microRNA, a promising biomarker for homeostatic and disease conditions ranging from cancer to HIV. First, an inkjet-printed paper SERS sensor has been developed to allow on-demand production of a customizable and multiplexable single-step lateral flow assay for miRNA quantification. Second, as miRNA concentrations commonly exist in relatively low concentrations, amplification methods (e.g. PCR) are therefore required to facilitate quantification. This work presents a novel miRNA assay alongside a novel technique for quantification of nuclease driven nucleic acid amplification strategies that will allow SERS to be used directly with common amplification strategies for quantification of miRNA and other nucleic acid biomarkers.
In this review we will discuss the advances in plasmonic substrates fabricated on porous membranes, leading to SERS sensors that can collect samples via swabbing or dipping, clean up samples through separation, concentrate analytes by lateral flow focusing, and avoid the need for peripheral equipment. In particular, we will focus on inkjet-fabricated devices, which may present the best opportunity for scale-up via roll-to-roll manufacturing. We will also discuss the directions that flexible SERS sensors are moving the field, such as simple fabrication techniques, new support materials, SERS swabs, and SERS-active tapes and films.
View contact details
No SPIE Account? Create one
